BioStock Studio: Ultimovacs reaches key milestones with UV1

BioStock Studio: Ultimovacs reaches key milestones with UV1

Norwegian Ultimovacs has made some big announcements recently, including discussions for a fifth phase II clinical trial with universal cancer vaccine UV1, a private...
Anders Månsson, CEO RhoVac

BioStock Studio: RhoVac CEO comments on latest news flow

Lund-based RhoVac has had an intensive news flow so far this fall. BioStock invited CEO Anders Månsson to the studio to talk about the...

BioStock Studio: Xintela expands to venous leg ulcers

Xintela has broadened the clinical development of its stem cell product XSTEM to include venous leg ulcers, the most common form of difficult-to-heal wounds...

BioStock Studio: Alligator Bioscience’s long-term value driver

Alligator Bioscience has just announced that it is carrying out a rights issue worth approximately 257 million SEK. CEO Søren Bregenholt came by the BioStock Studio...

BioStock Studio: Cereno Scientific’s CEO about the milestone in the CS1...

Last week, Spotlight-listed Cereno Scientific got the acceptance from the FDA regarding their IND application for initiating a phase II trial with CS1 in...

BioStock Studio: Immunicum’s CEO on the company’s new therapeutic focus

Swedish immunotherapy company Immunicum has broadened its cancer treatment focus with the addition of drug candidate DCP-001 thanks to the merger with Dutch biotech...

BioStock Live: World Sepsis Day Seminar with Aptahem

September 13 is #WorldSepsisDay, and this year marks the 10th anniversary of the occasion. Events in all parts of the world are taking place to...

BioStock Studio: Cereno’s CEO is looking forward to trial start

Gothenburg-based Cereno Scientific has made a number of preparations for the coming initiation of the phase II trial with their candidate CS1 in the...

BioStock Studio: CLS’ CEO and VP Clinical Affairs on Q2

Yesterday, medtech company Clincal Laserthermia Systems published its report for the second quarter of the year. The report highlighted, among other things, the company's...

BioStock studio: Xintela looks ahead

Yesterday Sven Kili, board member and CMO of Swedish company Xintela visited Biostock’s studio. Xintela works within the fields of regenerative medicine and cancer, focusing particularly...